University Medical Centre Groningen

Groningen 9713 GZ

4 studies enrolling now · 9 studies all time

What they study most

Cutaneous Melanoma, Stage II, Heart Failure, Hemophilia A, KRAS G12C-mutated Solid Tumors, Lung Cancer, KRAS, NRAS, HRAS-mutated NSCLC, Left Ventricular Dysfunction, Locally Advanced Solid Tumor, Lung Cancer Stage IV, Advanced Solid Tumor, Cancer, Melanoma, Metastatic Solid Tumor, Mild or Moderate Surgical Bleeding, Non-Small Cell Lung Cancer, NSCLC

Studies at this site

• Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC — Recruiting now
• A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1) — Recruiting now
• Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma — Recruiting now
• Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells — Enrolling by invitation
• Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma — Running, not enrolling
• Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery — Completed
• A Study of Fibrocaps™ in Surgical Bleeding — Completed
• INcrease Of VAgal TonE in CHF — Stopped early
• GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer — Stopped early